11![Final Draft Review Pharmacometrics Review NDA: DRUG NAME: DOSAGE STRENGTH: Final Draft Review Pharmacometrics Review NDA: DRUG NAME: DOSAGE STRENGTH:](https://www.pdfsearch.io/img/345794ad14091455b7df3703b449c925.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
12![Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology](https://www.pdfsearch.io/img/237a3004931fdbe1c6178263f9dc1ba1.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
13![Best starting dose meeting the criteria is 0.75 ?g/kg/min. Best starting dose meeting the criteria is 0.75 ?g/kg/min.](https://www.pdfsearch.io/img/ac8f79751b61256a42b465e6758b060b.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
14![Argatroban - FDA Presentation Slides Argatroban - FDA Presentation Slides](https://www.pdfsearch.io/img/7569736a506c1a6248e7b8c5d19fd418.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
15![July 6, 2012 Press Release Mitsubishi Tanabe Pharma Corporation Launch of Argatroban, a Selective Antithrombin Agent, in UK Osaka, Japan, July 6, [removed]Mitsubishi Tanabe Pharma Corporation (hereafter, MTPC; July 6, 2012 Press Release Mitsubishi Tanabe Pharma Corporation Launch of Argatroban, a Selective Antithrombin Agent, in UK Osaka, Japan, July 6, [removed]Mitsubishi Tanabe Pharma Corporation (hereafter, MTPC;](https://www.pdfsearch.io/img/544da3e7c48aed479ff89f4209f23934.jpg) | Add to Reading ListSource URL: www.mt-pharma.co.jpLanguage: English - Date: 2012-07-05 06:31:08
|
---|
16![[removed]Federal Register / Vol. 71, No[removed]Wednesday, May 3, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES [removed]Federal Register / Vol. 71, No[removed]Wednesday, May 3, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://www.pdfsearch.io/img/e8ce059798cfe0bb1ce9c1001d11689a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
17![](https://www.pdfsearch.io/img/2f92104cbdc3e26e8ce326fb6042d585.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
18![](https://www.pdfsearch.io/img/bda684d9a3b23efad5de214aa8dd4183.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
19![](https://www.pdfsearch.io/img/cc4dc6b9cb194316eeffb753f1f57f7f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
20![](https://www.pdfsearch.io/img/59212d805b1cf3a601e5acf0e81f6865.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|